Travelers With Sickle Cell Disease

被引:14
作者
Willen, Shaina M. [1 ]
Thornburg, Courtney D. [2 ]
Lantos, Paul M. [3 ]
机构
[1] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[2] Univ San Diego, Med Ctr, Div Pediat Hematol & Oncol, San Diego, CA 92110 USA
[3] Duke Univ, Med Ctr, Div Gen Internal Med, Durham, NC USA
基金
美国国家卫生研究院;
关键词
VENOUS THROMBOEMBOLISM; PNEUMOCOCCAL DISEASE; RISK-FACTORS; CHILDREN; ANEMIA; PROPHYLAXIS; HYDROXYUREA; PENICILLIN; MALARIA; AFRICA;
D O I
10.1111/jtm.12142
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Sickle cell disease (SCD) is the most common genetic disease among persons with African ancestry. This article provides a background to SCD and reviews many important aspects of travel preparation in this population. Methods. The medical literature was searched for studies on travel-associated preparedness and complications in individuals with SCD. Topics researched included malaria, bacterial infections, vaccinations, dehydration, altitude, air travel, and travel preparedness. Results. There is very little published literature that specifically addresses the risks faced by travelers with SCD. Rates of medical complications during travel appear to be high. There is a body of literature that describes complications of SCD in indigenous populations, particularly within Africa. The generalizability of these data to a traveler is uncertain. Combining these sources of data and the broader medical literature, we address major travel-related questions that may face a provider preparing an individual with SCD for safe travel. Conclusions. Travelers with SCD face considerable medical risks when traveling to developing tropical countries, including malaria, bacterial infections, hypovolemia, and sickle cell-associated vaso-occlusive crises. For individuals with SCD, frank counseling about the risks, vigilant preventative measures, and contingency planning for illness while abroad are necessary aspects of the pre-travel visit.
引用
收藏
页码:332 / 339
页数:8
相关论文
共 59 条
[1]   Empirical antimicrobial therapy for traveler's diarrhea [J].
Adachi, JA ;
Ostrosky-Zeichner, L ;
DuPont, HL ;
Ericsson, CD .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (04) :1079-1083
[2]   Protective effects of the sickle cell gene against malaria morbidity and mortality [J].
Aidoo, M ;
Terlouw, DJ ;
Kolczak, M ;
McElroy, PD ;
ter Kuile, FO ;
Kariuki, S ;
Nahlen, BL ;
Lal, AA ;
Udhayakumar, V .
LANCET, 2002, 359 (9314) :1311-1312
[3]  
Aken'ova Y. A., 1998, Central African Journal of Medicine, V44, P102
[4]   ACUTE ILLNESS IN NIGERIAN CHILDREN WITH SICKLE-CELL-ANEMIA [J].
AKINYANJU, O ;
JOHNSON, AO .
ANNALS OF TROPICAL PAEDIATRICS, 1987, 7 (03) :181-186
[5]   Variation in the pattern of bacterial infection in patients with sickle cell disease requiring admission [J].
Akuse, RM .
JOURNAL OF TROPICAL PEDIATRICS, 1996, 42 (06) :318-323
[6]   PROTECTION AFFORDED BY SICKLE-CELL TRAIT AGAINST SUBTERTIAN MALARIAL INFECTION [J].
ALLISON, AC .
BRITISH MEDICAL JOURNAL, 1954, 1 (4857) :290-294
[7]   Higher resistance to Plasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya [J].
Aluoch, JR .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (06) :568-571
[8]   Associated morbidities in children with sickle-cell anaemia presenting with severe anaemia in a malarious area [J].
Ambe, JP ;
Fatunde, JO ;
Sodeinde, OO .
TROPICAL DOCTOR, 2001, 31 (01) :26-27
[9]  
Awotua-Efebo O, 2004, Niger J Med, V13, P40
[10]   A global perspective on sickle cell disease [J].
Aygun, Banu ;
Odame, Isaac .
PEDIATRIC BLOOD & CANCER, 2012, 59 (02) :386-390